Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04585750
Recruitment Status : Recruiting
First Posted : October 14, 2020
Last Update Posted : October 8, 2021
Sponsor:
Information provided by (Responsible Party):
PMV Pharmaceuticals, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 1, 2024
Estimated Study Completion Date : December 15, 2025